Delivery Order SPE2DB22D9309-SPE2DB24FAF27

Award Date 9/3/24
Potential Completion Date 9/24/24
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of NEXPLANON 68 MG IMPLANTS, a contraceptive device, with a ceiling value of $25,728.84. The contract is a firm fixed-price delivery order with no set-aside designation, and has an ultimate completion date of September 6, 2024. This contract is part of a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of NEXPLANON 68 MG IMPLANTS, a type of contraceptive product. The contract has a firm-fixed-price pricing structure and a ceiling value of $2,858.76. The period of performance runs through July 17, 2024. This delivery order is issued under a larger indefinite...
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The contract has a ceiling value of $15,729.50 and covers the procurement of NEXPLANON 68 MG IMPLANTS, a prescription contraceptive device. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA, valued at...
The U.S. Defense Logistics Agency (DLA) awarded a $25,728.84 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of 4,565,176,099 units of the NEXPLANON 68 MG IMPLANTS contraceptive product. This delivery order is part of a larger single-award indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which runs through December 31, 2025. The IDC allows the DLA to issue...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of NEXPLANON 68 MG IMPLANTS, a contraceptive device, with a ceiling value of $3,471.55 and a period of performance through December 27, 2024. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of NEXPLANON 68 MG IMPLANTS, a contraceptive device, with a ceiling value of $4,165.86 and a period of performance through June 20, 2025. The contract is not set aside and is awarded under DMS Pharmaceutical Group's existing $499,999,999 Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of NEXPLANON 68 MG IMPLANTS, a contraceptive implant, to support the recurring medical supply needs of military health facilities. The award is part of a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of NEXPLANON 68 MG IMPLANTS, a contraceptive device, with a ceiling value of $4,288.14 and a period of performance through March 29, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $21,440.70 firm fixed-price contract is for the delivery of NEXPLANON 68 MG IMPLANTS, a contraceptive device, with a period of performance through April 4, 2024. The contract is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Vehicle (IDV) with the DLA, contract SPE2DB24FZF96, valued...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of NEXPLANON 68 MG IMPLANTS, a type of contraceptive implant. The contract is a firm fixed-price delivery order with a ceiling value of $2,777.24 and an ultimate completion date of April 23, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS...
  • SPE2DB22D9309
    Indefinite Delivery Contract
  • SPE2DB22D9309-SPE2DB24FAF27
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of NEXPLANON 68 MG IMPLANTS, a contraceptive device, and has a ceiling value of $17,152.56. The contract is a firm fixed-price delivery order with no set-aside designation, and the ultimate completion date is September 24, 2024.

The contract is part of a larger indefinite delivery contract (IDC) awarded by the DLA under the SPE2DB program, which has a potential value of up to $499,999,999 and runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a wide range of pharmaceutical items to support the medical supply needs of military healthcare facilities worldwide.

Through this contract and the broader IDC, DMS Pharmaceutical Group provides a comprehensive array of medications, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to the U.S. Department of Defense and Department of Veterans Affairs, solidifying its position as a crucial supplier in the federal pharmaceutical supply chain.

Generated 12/3/24, 9:55 AM